- Abstract Number: 1455
B and T Cell Immunologic Features Associated with Higher Disease Activity Score and Focus Score in Primary Sjögren Syndrome
- Abstract Number: 1416
B Cell Profile for Early Identification of Optimal Responders to TNF-inhibitors in Rheumatoid Arthritis
- Abstract Number: 971
B Cell ROCK1 Promotes Germinal Center Responses and Is Required for Optimal Humoral Immunity
- Abstract Number: 883
B Cell-specific MyD88 Regulates Pathology After Disease Onset in Murine Lupus
- Abstract Number: 1880
Baricitinib 4 Mg and 2 Mg Once Daily Reduced Pain in Both Patients Who Were Opioid Users and Non-users in Active Rheumatoid Arthritis: A Post-hoc Analysis of Phase 3 Trials
- Abstract Number: 1407
Baricitinib Provides Better Pain Relief Across All Disease Activity Levels Compared with Placebo and Adalimumab in Rheumatoid Arthritis
- Abstract Number: 1142
Barriers and Facilitators of Medication Adherence Among Minority SLE Patients: A Qualitative Study
- Abstract Number: 609
Baseline Characteristics and Natural History of Radiographic versus Non-radiographic Axial Spondyloarthritis: 5 Years Follow-up of the Desir Cohort
- Abstract Number: 2726
Baseline Characteristics and Quality of Life Metrics in Non-Infectious Uveitis
- Abstract Number: 2381
Baseline Characteristics Associated with Sustained SDAI Remission Following Treatment with Abatacept in Combination with MTX Compared with Abatacept Placebo in Combination with MTX in ACPA Positive Patients with Early RA
- Abstract Number: 2868
Baseline Clinical and Serological Findings in Pediatric-Onset Discoid Lupus Erythematosus: Analysis of a Multicenter Retrospective Cohort Study
- Abstract Number: 2
Baseline Cytotoxic Gene Expression Associates with Ustekinumab Response in Systemic Lupus Erythematosus
- Abstract Number: 1453
Baseline EULAR Sjögren’s Syndrome Patient-Reported Index Has a Significant Impact on the Longitudinal Course of Sjögren’s Syndrome
- Abstract Number: 1626
Baseline Serum Osteopontin (OPN) Level Is Associated with Early Coronary Artery-calcification and Its Progression in Patients with Systemic Lupus Erythematosus
- Abstract Number: 1650
Baseline Skin Score, Older Age and CD34-selection Influence the Outcome of Autologous Stem Cell Transplantation for Systemic Sclerosis – Results of a Prospective Non-interventional Study from the European Society for Blood & Marrow Transplantation (EBMT)
- Abstract Number: 720
Baseline Subject Demographics and Disease Characteristics in a Phase 3 Study of Safety and Efficacy of Lenabasum in Diffuse Cutaneous Systemic Sclerosis
- Abstract Number: 2040
BATF2 Contributes to Interferon Dysregulation in SLE Keratinocytes
- Abstract Number: 1189
Baylor Rheumatology Initiative: Developing and Guiding Engagement (BRIDGE) Transition Pathway Creation and Implementation
- Abstract Number: 1059
BDCA2 Targeting of Human Plasmacytoid Dendritic Cells via CBS004 Reverts Dependent IFN Activation and Tissue Fibrosis in vitro and in vivo
- Abstract Number: 45
bDMARD-experienced Filgotinib-treated Patient Samples Exhibit a Partial Reversion to the Peripheral Molecular Profile of a Demographically Matched Healthy Population
- Abstract Number: 2545
Belatacept in Systemic Lupus Erythematosus (SLE) Kidney Transplant Patients
- Abstract Number: 1002
Beneficial Effect of Angiotensin Receptor Blocker in a Spondyloarthritis Animal Model
- Abstract Number: 22
Beta-2 Glycoprotein I as a DNA- and NET-binding Protein
- Abstract Number: 1858
Beta-2-Glycoprotein-I IgA Antibodies Predict Coronary Plaque Burden, Progression and Moderate the Effect of Inflammation on Atherosclerosis in Rheumatoid Arthritis
- Abstract Number: 2017
Beyond Genes—a Multi-omic Analysis of Monozygotic Twins Discordant for Rheumatoid Arthritis
- Abstract Number: 167
Bioethics for the Rheumatologist: A Needs-Assessment, Curriculum Development, and Knowledge Assessment of Bioethical Topics for Rheumatology Trainees
- Abstract Number: 110
Bioinformatics Analysis of Transcriptomics Data Reveals That SRSF1 Is a Novel Molecular Brake for the T Cell Activation Program and Controls Key Cytokine Signaling Genes Implicated in Systemic Lupus Erythematosus
- Abstract Number: 683
Biologic Differences Between Type 1 and 2 Lupus
- Abstract Number: 1540
Biologic Use and Reasons for Switching Biologic Therapy in Patients with Non-radiographic Axial Spondyloarthritis in the United States:Findings from a US Survey
- Abstract Number: 1693
Biological Therapy in Neurobehçet: Multicenter Study of 31 Patients
- Abstract Number: 1272
Biological Therapy in Non Ischaemic Optic Neuritis Associated to Immune-mediated Inflammatory Diseases: Multicenter Study
- Abstract Number: 2113
Biological Therapy Is Associated with Faster Recovery and Lower Frequency of Switch Treatment in Patients with Chikungunya Fever
- Abstract Number: 1895
Biologics Prevent Cardiovascular Events in Rheumatoid Arthritis by Inhibiting Non-calcified Coronary Plaque Progression and Stabilizing Vulnerable Plaques
- Abstract Number: 11
Biomarker Changes for Patients with Rheumatoid Arthritis Receiving Tofacitinib with Methotrexate or Glucocorticoids vs Tofacitinib Monotherapy
- Abstract Number: 1767
Biomarker Profiling Reveals Novel Mechanistic Insights into Ustekinumab Therapeutic Responses in Systemic Lupus Erythematosus
- Abstract Number: 2009
Biomarkers Identified by Serum Inflammatory Profile Analysis to Predict Biologic Treatment Response in Rheumatoid Arthritis Patients
- Abstract Number: 1889
Biomarkers of Clinical Relapse and Radiological Progression in Patients with Rheumatoid Arthritis in Remission: Observational Study of 5 Years of Follow-up
- Abstract Number: 724
Biomechanical Properties of Skin for Assessment of Scleroderma: A Systemic Review
- Abstract Number: 1080
Biosimilar Etanercept Use in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis: The RHUMADATA® Registry Experience
- Abstract Number: 2115
BK Polyomavirus Viremia and Viruria in Patients with Autoimmune Connective Tissue Diseases: Impact of Immunosuppressants
- Abstract Number: 123
Blockade of Antigen-specific T Cell Activation by a Non-Depleting Anti-HLA-DR Monoclonal Antibody with a Unique Binding Epitope
- Abstract Number: 1490
Blockage of TNFα and IL-12/23 Improves Depressive Symptoms in Patients with Psoriatic Arthritis – Analysis of Clinical Trial Data
- Abstract Number: 2195
BMI Has Minimal Effect on Reduction of Symptoms in Patients with Osteoarthritis of the Knee Treated with Diclofenac 1% Gel
- Abstract Number: 2463
Body Composition and Fat Distribution in Patients with Psoriasis or Psoriatic Arthritis
- Abstract Number: 2599
Body Composition and Nailfold Videocapillaroscopy Patterns in a Cohort of Systemic Sclerosis Patients
- Abstract Number: 1867
Body Composition in Myositis Patients Is Negatively Changed Compared to Healthy Controls and the Changes Are Associated with Disease Activity and Duration, Skeletal Muscle Involvement and Physical Activity and Nutritional Status
- Abstract Number: 2068
Body Mass Index and Systemic Corticosteroid Use as Indicators of Disease Burden and Their Influence on the Safety Profile of Certolizumab Pegol Across Indications
- Abstract Number: 694
Body Mass Index at Time of Diagnosis Is Predictive of Future Disease Activity in SLE
- Abstract Number: 273
Bone Health in Lupus: Findings from the Southern California Lupus Registry
- Abstract Number: 2222
Bone Health: An Independent Predictor of Coronary Artery Disease
- Abstract Number: 904
Bone Manifestations in Gaucher Disease: A Monocentric Study of 128 Patients
- Abstract Number: 2221
Bone Metabolism Impairment in Heart Transplant: Results from a Prospective Cohort Study
- Abstract Number: 2304
Bone Microstructure of Patients with Rheumatoid Arthritis: A HR-pQCT Study
- Abstract Number: 2207
Bone Mineral Density and Microarchitecture Among Chinese Patients with Rheumatoid Arthritis
- Abstract Number: 2440
Bone Mineral Density in Psoriatic Arthritis: Results from a Longitudinal Study
- Abstract Number: 2216
Bone Mineral Density of the Spine, Hip, and Distal Radius in Patients with Postmenopausal Osteoporosis
- Abstract Number: 1896
Breastfeeding in Women with Rheumatic Diseases
- Abstract Number: PP03
Bridging the Gap: Leveraging Social Media to Improve Patient Support; Build a Path to Collaborative Medicine
- Abstract Number: 1996
Bromodomain Inhibitor, I-BET762 Inhibits Production of Pro-inflammatory in Rheumatoid Arthritis Fibroblast-like Synoviocytes and Differentiation of Osteoclast
- Abstract Number: 1627
Bronchoalveolar Lavage Fluid Analysis and Mortality Risk in Systemic Lupus Erythematosus Patients with Pneumonia and Respiratory Failure
- Abstract Number: 974
Bruton’s Tyrosine Kinase (BTK) Inhibitors and Autoimmune Disease: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures
- Abstract Number: 967
Bruton’s Tyrosine Kinase (BTK) Pathway Is Active in Synovium at Various Stages of Rheumatoid Arthritis Disease Progression
- Abstract Number: 1903
BTK Overexpression Is Associated with the Risk of Lymphoma in Primary Sjögren’s Syndrome: Data from Whole Blood Transcriptome of 346 Patients Followed-up Prospectively for 10 Years
- Abstract Number: 2477
Burden of Disease at Treatment Initiation Among Biologic-Naïve Patients with Oligoarticular versus Polyarticular Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry
- Abstract Number: 2295
Burden of Systemic Lupus Erythematosus Among Korean Women in Childbearing Years Based on the National Health Insurance Service Data
2019 ACR/ARP Annual Meeting
November 8-13, 2019. Atlanta, GA.